Executive summary
Clorox forecasts a 13% to 14% sales increase for fiscal 2027, largely driven by its recent acquisition of Purell-maker Gojo Industries. While the company faces ongoing consumer spending pressures, the addition of Purell positions its health and hygiene segment as the majority of total sales.
What happened
Clorox issued guidance for fiscal 2027 projecting net sales growth of 13% to 14%, with adjusted earnings per share expected to reach $5.70 to $6.00 - a 3% to 8% increase from the prior year. The forecast follows the company's April completion of its Gojo Industries acquisition, which added the Purell brand to its portfolio. The acquisition accounts for 9.5% of the projected sales growth, while organic growth is expected to contribute only 3.5% to 4.5%. The health and hygiene segment now represents more than half of Clorox's total sales.
Why the stock moved
The stock likely reacted to the upbeat annual sales forecast, as investors welcomed clarity on growth prospects following years of operational challenges. The guidance suggests Clorox is stabilizing after completing a $580 million enterprise resource planning system overhaul in February and recovering from supply chain disruptions and a 2023 cyberattack. However, management also tempered expectations by warning that consumers remain highly value-conscious and that category growth will likely stay below historical levels due to subdued volume and competitive pressures.
Bigger picture
Clorox is transitioning from crisis management to optimization after a difficult multi-year period marked by pandemic-related supply issues, inflation, and costly IT infrastructure upgrades. The company expects strong cash flow generation of 11% to 13% as a percentage of net sales in fiscal 2027, which should comfortably support its dividend. With 49 consecutive years of dividend increases, Clorox is positioned to join the elite Dividend Kings group in 2027. At a price-to-earnings ratio of roughly 16.8 based on midpoint guidance, the stock trades at a discount relative to its brand strength across cleaning, disinfecting, and hygiene categories.
What investors watch
Investors should monitor whether organic sales growth can accelerate beyond the modest 3.5% to 4.5% guidance, signaling genuine improvement in consumer demand rather than reliance on acquisitions. The success of the ERP system integration will be critical - any operational hiccups could pressure margins. Additionally, watch for updates on consumer spending trends and competitive dynamics in the cleaning and hygiene categories, as management has cautioned that value-conscious shoppers and elevated competition may limit pricing power and volume growth in the near term.
Get our top market beating stocks free here
#earnings
#company
#product